Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases

JAMA

Volumn 306, Issue 8, 2011, Pages 840-847

  Bell, Chaim M ^a,b,c,e   Brener, Stacey S ^a,b,c   Gunraj, Nadia ^e   Huo, Cindy ^e   Bierman, Arlene S ^a,b,e   Scales, Damon C ^a,e,f   Bajcar, Jana ^a,f   Zwarenstein, Merrick ^a,e   Urbach, David R ^a,b,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; PROTON PUMP INHIBITOR; STEROID; WARFARIN;

AGED; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INHALER; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT WITHDRAWAL; CANADA; DRUG THERAPY; HOSPITAL; MEDICATION ERROR; PATIENT CARE; POLYPHARMACY; RISK; STATISTICS; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COHORT STUDIES; CONTINUITY OF PATIENT CARE; DRUG THERAPY; FEMALE; HOSPITALIZATION; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; MALE; MEDICATION ADHERENCE; MEDICATION ERRORS; ODDS RATIO; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; POLYPHARMACY; PRESCRIPTIONS; RISK;

EID: 80052073777     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1206     Document Type: Article

References (58)

1. DeVault KR, Castell DO; Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 1999;94(6):1434-1442.
2. Fodor JG, Frohlich JJ, Genest JJ Jr, McPherson PR; Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. Recommendations for the management and treatment of dyslipidemia. CMAJ. 2000;162(10):1441-1447.
3. Green C.J., Hadorn D.C., Bassett K., Kazanjian A. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. Can J Cardiol. 1997;13(9):811-815. (Pubitemid 27460415)
4. Hart R.G., Halperin J.L., Pearce L.A., et al Stroke Prevention in Atrial Fibrillation Investigators. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med. 2003;138(10):831-838. (Pubitemid 38124645)
5. MacLean D.R., Petrasovits A., Connelly P.W., Joffres M., O'Connor B., Little J.A.; Canadian Heart Health Surveys Research Group. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Can J Cardiol. 1999; 15(4):434-444. (Pubitemid 29224875)
6. Harrington R.A., Becker R.C., Ezekowitz M., et al. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3)(suppl):513S-548S. (Pubitemid 39302604)
7. O'Donnell D.E., Aaron S., Bourbeau J., et al Canadian Thoracic Society. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2003. Can Respir J. 2003; 10(suppl A):11A-65A. (Pubitemid 36986735)
8. Kripalani S., Jackson A.T., Schnipper J.L., Coleman E.A. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007;2(5):314-323. (Pubitemid 350020008)
9. Kripalani S., LeFevre F., Phillips C.O., Williams M.V., Basaviah P., Baker D.W. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831-841. (Pubitemid 46333948)
10. Bell C.M., Rahimi-Darabad P., Orner A.I. Discontinuity of chronic medications in patients discharged from the intensive care unit. J Gen Intern Med. 2006; 21(9):937-941. (Pubitemid 44141762)
11. Bauer T.T., Torres A. Aerosolized beta2-agonists in the intensive care unit: just do it. Intensive Care Med. 2001;27(1):3-5. (Pubitemid 32208960)
12. Cook D, Guyatt G, Marshall J, et al; Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338(12):791-797.
13. Perkins GD, McAuley DF, Thickett DR, Gao F. The Beta-Agonist Lung Injury Trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med. 2006;173(3):281-287.
14. Gurwitz J.H., Glynn R.J., Monane M., et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993;83(5):711-716. (Pubitemid 23143002)
15. Benner J.S., Glynn R.J., Mogun H., Neumann P.J., Weinstein M.C., Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-461. (Pubitemid 34787476)
16. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994;154(4):433-437. (Pubitemid 24072217)
17. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Levin R., Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10(7 pt 1):697-704. (Pubitemid 27313814)
18. Rudd P. Compliance with antihypertensive therapy: raising the bar of expectations. Am J Manag Care. 1998;4(7):957-966. (Pubitemid 28361605)
19. Levy A.R., O'Brien B.J., Sellors C., Grootendorst P., Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10(2):67-71. (Pubitemid 37028596)
20. Williams JI, Young W. A Summary of Studies on the Quality of Health Care Administrative Databases in Canada. In: Goel V, Williams JI, Anderson GM, Blackerstein-Hersch P, Fooks C, Naylor CD, eds. 2nd ed. Ottawa, ON: Canadian Medical Association; 1996: 339-345.
21. Juurlink D, Preyra C, Croxford R, et al. Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. Toronto, ON: Institute for Clinical Evaluative Sciences; 2006.
22. Katz SJ, Verrilli D, Barer ML. Canadians' use of US medical services. Health Aff (Millwood). 1998; 17(1):225-235.
23. Katz SJ, Cardiff K, Pascali M, Barer ML, Evans RG. Phantoms in the snow: Canadians' use of health care services in the United States. Health Aff (Millwood). 2002;21(3):19-31.
24. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458-1462.
25. Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000;15(11):776-781.
26. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288 (4):462-467. (Pubitemid 34787477)
27. Graves T., Hanlon J.T., Schmader K.E., et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med. 1997;157(19): 2205-2210. (Pubitemid 27451146)
28. Schneeweiss S., Seeger J.D., Maclure M., Wang P.S., Avorn J., Glynn R.J. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154(9): 854-864. (Pubitemid 33000813)
29. Schneeweiss S, Maclure M, Soumerai SB, Walker AM, Glynn RJ. Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. J Clin Epidemiol. 2002;55(8): 833-841.
30. Bell C.M., Bajcar J., Bierman A.S., Li P., Mamdani M.M., Urbach D.R. Potentially unintended discontinuation of long-term medication use after elective surgical procedures. Arch Intern Med. 2006;166(22):2525-2531. (Pubitemid 44913238)
31. Boockvar K., Fishman E., Kyriacou C.K., Monias A., Gavi S., Cortes T. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med. 2004;164(5):545-550. (Pubitemid 38314451)
32. Himmel W, Tabache M, Kochen MM. What happens to long-term medication when general practice patients are referred to hospital? Eur J Clin Pharmacol. 1996;50(4):253-257.
33. Moore C., Wisnivesky J., Williams S., McGinn T. Medical errors related to discontinuity of care from an inpatient to an outpatient setting. J Gen Intern Med. 2003;18(8):646-651. (Pubitemid 37047038)
34. Gleason KM, McDaniel MR, Feinglass J, et al. Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission. J Gen Intern Med. 2010;25(5):441-447.
35. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006; 166(5):565-571.
36. Schnipper JL, Hamann C, Ndumele CD, et al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009;169(8):771-780.
37. Institute for Health Improvement. How-to guide: prevent adverse drug events (medication reconciliation). http://www.ihi.org/knowledge/Pages/Tools/ HowtoGuidePreventAdverseDrugEvents.aspx. Accessed July 10, 2010.
38. Ball C, Kirkby M, Williams S. Effect of the critical care outreach team on patient survival to discharge from hospital and readmission to critical care: nonrandomised population based study. BMJ. 2003;327(7422):1014.
39. Brown JC. Rapid response teams: a narrative review. http://www.qhsj.org/ attachments/124-06.pdf. Accessed January 20, 2011.
40. Bajcar J.M., Kennie N., Einarson T.R. Collaborative medication management in a team-based primary care practice: an explanatory conceptual framework. Res Social Adm Pharm. 2005;1(3):408-429. (Pubitemid 44069572)
41. Gillen D., Wirz A.A., Neithercut W.D., Ardill J.E., McColl K.E. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut. 1999;44(4):468-475. (Pubitemid 29169945)
42. Sibon I., Orgogozo J.M. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004;62(7):1187-1189. (Pubitemid 38456516)
43. Waldum H.L., Arnestad J.S., Brenna E., Eide I., Syversen U., Sandvik A.K. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut. 1996;39(5):649-653. (Pubitemid 26426463)
44. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418-1428.
45. Kaushal R., Barker K.N., Bates D.W. How can information technology improve patient safety and reduce medication errors in children's health care? Arch Pediatr Adolesc Med. 2001;155(9):1002-1007. (Pubitemid 32824044)
46. Petersen LA, Brennan TA, O'Neil AC, Cook EF, Lee TH. Does housestaff discontinuity of care increase the risk for preventable adverse events? Ann Intern Med. 1994;121(11):866-872.
47. Maslove DM, Leiter RE, Griesman J, et al. Electronic versus dictated hospital discharge summaries: a randomized controlled trial. J Gen Intern Med. 2009;24(9):995-1001.
48. Coffey M, Cornish P, Koonthanam T, Etchells E, Matlow A. Implementation of admission medication reconciliation at two academic health sciences centres: challenges and success factors. Healthc Q. 2009;12 Spec No Patient:102-109.
49. Cornish P.L., Knowles S.R., Marchesano R., et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165(4):424-429. (Pubitemid 40280198)
50. Etchells E. Do pharmacists' presence on rounding teams reduce preventable adverse drug events in hospital general medical units? CMAJ. 2004;170(3):333. (Pubitemid 38223448)
51. Tam V.C., Knowles S.R., Cornish P.L., Fine N., Marchesano R., Etchells E.E. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005;173(5):510-515. (Pubitemid 41225048)
52. Bajcar JM, Wang L, Moineddin R, Nie JX, Tracy CS, Upshur RE. From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006. BMC Fam Pract. 2010;11:75.
53. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345-351.
54. Besdine R, Boult C, Brangman S, et al; American Geriatrics Society Task Force on the Future of Geriatric Medicine. Caring for older Americans: the future of geriatric medicine. J Am Geriatr Soc. 2005;53(6)(suppl):S245-S256.
55. Schwartz D, Wang M, Zeitz L, Goss ME. Medication errors made by elderly, chronically ill patients. Am J Public Health Nations Health. 1962;52:2018-2029.
56. Calkins D.R., Davis R.B., Reiley P., et al. Patientphysician communication at hospital discharge and patients'understanding of the postdischarge treatment plan. Arch Intern Med. 1997;157(9):1026-1030. (Pubitemid 27190893)
57. Cochrane RA, Mandal AR, Ledger-Scott M, Walker R. Changes in drug treatment after discharge from hospital in geriatric patients. BMJ. 1992;305(6855):694-696.
58. Landefeld C.S. Improving health care for older persons. Ann Intern Med. 2003;139(5 pt 2):421-424. (Pubitemid 38120870)